Ampure XP beads drug

Aliases

AMPure XP, Ampure XP beads

External links

DrugBank · PubChem

No related entities found.

Mentioned in (20)

Papers in which this entity is mentioned.

• Enhancer activation from transposable elements in extrachromosomal DNA. (2025)
• Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
• Machine-guided design of cell-type-targeting cis-regulatory elements. (2024)
• ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
• Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. (2023)
• Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation. (2022)
• Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. (2022)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Nanopore sequencing and assembly of a human genome with ultra-long reads. (2018)
• Picky comprehensively detects high-resolution structural variants in nanopore long reads. (2018)
• Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
• An open access pilot freely sharing cancer genomic data from participants in Texas. (2016)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.